Home NDC 31722-430-31 NDC 31722-430-31 - Eslicarbazepine acetate This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 31722-430
Requested NDC 31722-430-31
Package NDCs from labels 31722-430-60, 31722-430-31, 31722-430-32, 31722-430-90
Manufacturer Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit V
Effective date 2025-05-23
Current FDA listing Not matched in FDA.report NDC product tables
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 31722-430-31 Eslicarbazepine acetate 10 in 1 BLISTER PACK TABLET 10 2 31722-430-32 Eslicarbazepine acetate 10 in 1 CARTON TABLET 10 2 31722-430-60 Eslicarbazepine acetate 60 in 1 BOTTLE TABLET 60 2 31722-430-90 Eslicarbazepine acetate 90 in 1 BOTTLE TABLET 90 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 31722-430 ESLICARBAZEPINE ACETATE (ESLICARBAZEPINE ACETATE) TABLET [CAMBER PHARMACEUTICALS, INC.] 2 Current NDC, 4 package rows 20250524_6200ae2e-ac4e-41b6-a1c3-0ea00703d7e3.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 ยท 13 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join ESLICARBAZEPINE ACETATE ESLICARBAZEPINE ACETATE Aurobindo Pharma Limited 2067fb77-9657-44da-b430-02e8a4efacb5 2026-08-07 Warnings, Adverse reactions Exact identifier rxcui: 1482525 rxcui: 1482515 rxcui: 1482521 rxcui: 1482507 unii: BEA68ZVB2K Dr. Drop NMN Vital Balance (Drop No.1 Cream 90g) NMN (NICOTINAMIDE MONONUCLEOTIDE), ECTOIN (ECTOINE) Reedfresh Co., LTD 55d703ca-ff9d-0dbc-e063-6294a90ab6b1 2026-07-05 Warnings Exact identifier unii: 230OU9XXE4 Eslicarbazepine Acetate ESLICARBAZEPINE ACETATE Jubilant Cadista Pharmaceuticals Inc. 22d08671-ac0d-4e3d-8195-929bbb021125 2026-04-15 Warnings, Adverse reactions Exact identifier rxcui: 1482525 rxcui: 1482515 rxcui: 1482521 rxcui: 1482507 unii: BEA68ZVB2K Eslicarbazepine acetate ESLICARBAZEPINE ACETATE Torrent Pharmaceuticals Limited d279e461-2611-4f5c-938d-5d117612894f 2025-07-30 Warnings, Adverse reactions Exact identifier rxcui: 1482525 rxcui: 1482515 rxcui: 1482521 rxcui: 1482507 unii: BEA68ZVB2K Eslicarbazepine Acetate ESLICARBAZEPINE ACETATE Golden State Medical Supply, Inc. 3a3b3e50-6590-0040-e063-6294a90a84c1 2025-07-18 Warnings, Adverse reactions Exact identifier rxcui: 1482525 rxcui: 1482515 rxcui: 1482521 rxcui: 1482507 unii: BEA68ZVB2K Eslicarbazepine acetate ESLICARBAZEPINE ACETATE Camber Pharmaceuticals, Inc. 6200ae2e-ac4e-41b6-a1c3-0ea00703d7e3 2025-05-23 Warnings, Adverse reactions Exact identifier application number: ANDA211186 ndc (package): 31722-431-32 ndc (package): 31722-429-32 ndc (package): 31722-428-30 ndc (package): 31722-429-31 ndc (package): 31722-430-31 ndc (package): 31722-430-32 ndc (package): 31722-431-30 ndc (package): 31722-428-31 ndc (package): 31722-428-32 ndc (package): 31722-429-30 ndc (package): 31722-430-60 ndc (package): 31722-431-31 ndc (package): 31722-430-90 ndc (package): 31722-431-90 ndc (product): 31722-429 ndc (product): 31722-428 ndc (product): 31722-431 ndc (product): 31722-430 ndc11 (package): 31722043031 rxcui: 1482525 rxcui: 1482515 rxcui: 1482521 rxcui: 1482507 spl id: 35c91221-dff8-9144-e063-6394a90a57fb spl set id: 6200ae2e-ac4e-41b6-a1c3-0ea00703d7e3 unii: BEA68ZVB2K Eslicarbazepine Acetate ESLICARBAZEPINE ACETATE Lupin Pharmaceuticals, Inc. 999b341f-fe13-4dd9-bb95-9b0d6a817c4c 2025-05-07 Warnings, Adverse reactions Exact identifier rxcui: 1482525 rxcui: 1482515 rxcui: 1482521 rxcui: 1482507 unii: BEA68ZVB2K Eslicarbazepine Acetate ESLICARBAZEPINE ACETATE Ascend Laboratories, LLC 28efe9d2-9d7b-4a7c-8458-098456d06604 2025-04-14 Warnings, Adverse reactions Exact identifier rxcui: 1482525 rxcui: 1482515 rxcui: 1482521 rxcui: 1482507 unii: BEA68ZVB2K Eslicarbazepine Acetate ESLICARBAZEPINE ACETATE Dr.Reddys Laboratories Inc 190fccbc-da3f-b175-ac02-f2c4307a15c3 2025-01-30 Warnings, Adverse reactions Exact identifier rxcui: 1482525 rxcui: 1482515 rxcui: 1482521 rxcui: 1482507 unii: BEA68ZVB2K Aptiom ESLICARBAZEPINE ACETATE Sumitomo Pharma America, Inc. 3d0c9554-eaeb-4694-8089-00133fcadce3 2023-11-10 Warnings, Adverse reactions Exact identifier rxcui: 1482525 rxcui: 1482515 rxcui: 1482521 rxcui: 1482507 unii: BEA68ZVB2K ANUBISMED HA HYALURONIC ANUBIS COSMETICS SL eac771e2-4c1b-3808-e053-2995a90ac5fc 2023-09-05 Warnings Exact identifier unii: 230OU9XXE4 Anubis Barcelona DMAE, ZIRHAFIRM ANUBIS COSMETICS SL f2274f8c-08aa-eb02-e053-2a95a90a3998 2023-09-01 Warnings Exact identifier unii: 230OU9XXE4 Anubis Barcelona Spa Line ORYZA SATIVA (RICE) STARCH, PERLITE, PALMITIC ACID ANUBIS COSMETICS SL eb01a962-ab38-18ec-e053-2995a90acdeb 2023-09-01 Warnings Exact identifier unii: 230OU9XXE4
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.